Interpretation of new concepts and approaches in the ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.
10.3760/cma.j.cn121430-20230804-00579
- Author:
Zemeng LI
1
;
Yanhai MENG
;
Lulu LI
;
Yanbo ZHANG
Author Information
1. Division of Surgical Intensive Care Unit, Cardiac Surgery Department, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100037, China. Corresponding author: Zhang Yanbo, Email: yanbozhang@126.com.
- Publication Type:Journal Article
- MeSH:
Adult;
Humans;
COVID-19;
Respiration, Artificial;
Positive-Pressure Respiration;
Respiratory Distress Syndrome/therapy*;
Noninvasive Ventilation
- From:
Chinese Critical Care Medicine
2023;35(9):919-926
- CountryChina
- Language:Chinese
-
Abstract:
Acute respiratory distress syndrome (ARDS) continues to be one of the most life-threatening conditions for patients in the intensive care unit (ICU). The 2023 European Society of Intensive Care Medicine guidelines on ARDS: definition, phenotyping and respiratory support strategies (2023 Guideline) update the 2017 An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with ARDS (2017 Guideline), including 7 aspects of 3 topics of definitions, phenotyping, and respiratory support strategies [including high flow nasal cannula oxygen (HFNO), non-invasive ventilation (NIV), neuromuscular blocking agents (NMBA), extracorporeal life support (ECLS), positive end-expiratory pressure (PEEP) with recruitment maneuvers (RM), tidal volume (VT), and prone positioning]. 2023 Guideline review and summarize the literature since the publication of the 2017 Guideline, covering ARDS and acute hypoxemic respiratory failure, as well as ARDS caused by novel coronavirus infection. Based on the most recent medical evidence, the 2023 Guideline provide clinicians with new ideas and approaches for nonpharmacologic respiratory support strategies for adults with ARDS. This article provides interpretation of the new concepts, the new approaches, the new recommended grading and new levels of evidence for ARDS in the 2023 Guideline.
